James B. Thomas

3.0k total citations
74 papers, 1.9k citations indexed

About

James B. Thomas is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, James B. Thomas has authored 74 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 49 papers in Cellular and Molecular Neuroscience and 7 papers in Organic Chemistry. Recurrent topics in James B. Thomas's work include Neuropeptides and Animal Physiology (46 papers), Receptor Mechanisms and Signaling (41 papers) and Pharmacological Receptor Mechanisms and Effects (28 papers). James B. Thomas is often cited by papers focused on Neuropeptides and Animal Physiology (46 papers), Receptor Mechanisms and Signaling (41 papers) and Pharmacological Receptor Mechanisms and Effects (28 papers). James B. Thomas collaborates with scholars based in United States, Canada and United Kingdom. James B. Thomas's co-authors include Daniel J. Brass, D. Lindsley, F. Ivy Carroll, S. Wayne Mascarella, William A. Carlezon, Allison T. Knoll, Edward G. Meloni, Hernán A. Navarro, Richard B. Rothman and Dennis M. Zimmerman and has published in prestigious journals such as Journal of the American Chemical Society, Academy of Management Review and Technometrics.

In The Last Decade

James B. Thomas

73 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James B. Thomas United States	23	928	894	318	249	201	74	1.9k
Jennifer L. Perry United States	31	852 0.9×	1.2k 1.3×	92 0.3×	416 1.7×	41 0.2×	55	3.8k
Wenxia Zhou China	36	1.5k 1.6×	409 0.5×	146 0.5×	345 1.4×	559 2.8×	232	4.7k
Martin Reddington Germany	26	917 1.0×	1.1k 1.3×	62 0.2×	61 0.2×	138 0.7×	64	2.3k
Richard Williams United States	23	1.4k 1.6×	471 0.5×	114 0.4×	96 0.4×	177 0.9×	42	3.2k
Richard B. Carter United States	26	589 0.6×	995 1.1×	127 0.4×	186 0.7×	85 0.4×	69	3.4k
Elizabeth M. Doherty United States	22	384 0.4×	135 0.2×	378 1.2×	112 0.4×	550 2.7×	46	2.3k
Richard J. Mead United Kingdom	19	903 1.0×	253 0.3×	41 0.1×	79 0.3×	93 0.5×	47	2.6k
Christophe Morin France	31	1.0k 1.1×	398 0.4×	258 0.8×	141 0.6×	12 0.1×	124	4.2k
J. R. Cooper United States	25	699 0.8×	396 0.4×	49 0.2×	151 0.6×	49 0.2×	62	2.5k
José Guimón Spain	26	441 0.5×	403 0.5×	27 0.1×	215 0.9×	51 0.3×	126	2.3k

Countries citing papers authored by James B. Thomas

Since Specialization

Citations

This map shows the geographic impact of James B. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Thomas more than expected).

Fields of papers citing papers by James B. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Thomas. The network helps show where James B. Thomas may publish in the future.

Co-authorship network of co-authors of James B. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Thomas. A scholar is included among the top collaborators of James B. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Thomas. James B. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kormos, Chad M., Pauline W. Ondachi, Scott P. Runyon, et al.. (2018). Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-N-[1R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic). Journal of Medicinal Chemistry. 61(17). 7546–7559. 4 indexed citations

Ondachi, Pauline W., Chad M. Kormos, Scott P. Runyon, et al.. (2018). Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3R)-7-Hydroxy-N-[(1S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic). Journal of Medicinal Chemistry. 61(17). 7525–7545. 8 indexed citations

Kormos, Chad M., Pauline W. Ondachi, Scott P. Runyon, et al.. (2017). Simple Tetrahydroisoquinolines Are Potent and Selective Kappa Opioid Receptor Antagonists. ACS Medicinal Chemistry Letters. 8(7). 742–745. 9 indexed citations

Narayanan, Sanju, Rangan Maitra, Jeffrey R. Deschamps, et al.. (2016). Discovery of a novel small molecule agonist scaffold for the APJ receptor. Bioorganic & Medicinal Chemistry. 24(16). 3758–3770. 24 indexed citations

Kormos, Chad M., Scott P. Runyon, James B. Thomas, et al.. (2016). Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of replacement of the 3-hydroxyphenyl group with pyridine or thiophene bioisosteres. Bioorganic & Medicinal Chemistry. 24(16). 3842–3848. 4 indexed citations

Carroll, F. Ivy, Chad M. Kormos, Rangan Maitra, et al.. (2015). Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents. Bioorganic & Medicinal Chemistry. 23(19). 6379–6388. 14 indexed citations

Thomas, James B., Robert W. Wiethe, O. Srinivas, et al.. (2014). Identification of 1-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1 H -pyrazol-3-yl]carbonyl}amino)cyclohexane Carboxylic Acid as a Selective Nonpeptide Neurotensin Receptor Type 2 Compound. Journal of Medicinal Chemistry. 57(12). 5318–5332. 20 indexed citations

Acharya, S. N., et al.. (2014). Identification of Cercospora leaf spot resistance among fenugreek accessions and characterization of the pathogen. Australian Journal of Crop Science. 8(6). 822–830. 9 indexed citations

Hershberger, Paul, Michael P. Hedrick, Satyamaheshwar Peddibhotla, et al.. (2013). Imidazole-derived agonists for the neurotensin 1 receptor. Bioorganic & Medicinal Chemistry Letters. 24(1). 262–267. 14 indexed citations

10.

Scanio, Marc J. C., Lei Shi, Irene Drizin, et al.. (2010). Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Nav1.8 sodium channel with efficacy in a model of neuropathic pain. Bioorganic & Medicinal Chemistry. 18(22). 7816–7825. 27 indexed citations

11.

Thomas, Brian F., et al.. (2005). Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities. Bioorganic & Medicinal Chemistry. 13(18). 5463–5474. 23 indexed citations

12.

Thomas, James B., Linda Dykstra, Richard M. Allen, et al.. (2004). Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist. European Journal of Pharmacology. 501(1-3). 111–119. 106 indexed citations

13.

Carroll, F. Ivy, Li Zhang, S. Wayne Mascarella, et al.. (2003). Discovery of the First N-Substituted 4β-Methyl-5-(3-hydroxyphenyl)morphan To Possess Highly Potent and Selective Opioid δ Receptor Antagonist Activity. Journal of Medicinal Chemistry. 47(2). 281–284. 13 indexed citations

14.

Zaki, Paulette A., Duane E. Keith, James B. Thomas, F. Ivy Carroll, & Christopher J. Evans. (2001). Agonist-, Antagonist-, and Inverse Agonist-Regulated Trafficking of the δ-Opioid Receptor Correlates with, but Does Not Require, G Protein Activation. Journal of Pharmacology and Experimental Therapeutics. 298(3). 1015–1020. 18 indexed citations

15.

Thomas, James B., Robert N. Atkinson, RB Rothman, et al.. (2000). 4-[(8-Alkyl-8-azabicyclo[3.2.1]octyl-3-yl)-3-arylanilino]-N,N-diethylbenzamides: high affinity, selective ligands for the delta opioid receptor illustrate factors important to antagonist activity. Bioorganic & Medicinal Chemistry Letters. 10(11). 1281–1284. 7 indexed citations

16.

Xu, Heng, Akihiro Hashimoto, Kenner C. Rice, et al.. (2000). Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [35S]GTP-?-S functional binding assay. Synapse. 39(1). 64–69. 25 indexed citations

17.

Thomas, James B., Robert N. Atkinson, Richard B. Rothman, et al.. (1999). Optically pure (−)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzamide displays selective binding and full agonist activity for the δ opioid receptor. Bioorganic & Medicinal Chemistry Letters. 9(23). 3347–3350. 6 indexed citations

18.

Thomas, James B., S. Wayne Mascarella, Jason P. Burgess, et al.. (1998). N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonists. Bioorganic & Medicinal Chemistry Letters. 8(22). 3149–3152. 5 indexed citations

19.

Thomas, James B., et al.. (1989). Optimal coding schemes for conflict-free channel access. IEEE Transactions on Communications. 37(10). 1004–1013. 2 indexed citations

20.

Pasternack, Bernard S., Milton Sobel, & James B. Thomas. (1987). Group-testing, halving procedures, and binary search. Communication in Statistics- Theory and Methods. 16(10). 2851–2871. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact